CompletedInterventionalPhase 3Updated May 30, 2011
A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy | NCT01637246 | Trialant
CompletedObservationalUpdated Sep 21, 2012
A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy
ClinicalTrials.gov ID
NCT01637246
Lead Sponsor
AllerganINDUSTRY
Overall Status
Completed
Study Type
Observational
Enrollment
4,385Actual
Last Update Posted
Sep 21, 2012Estimated
Start Date
Apr 2009
Primary Completion Date
Nov 2011Actual
Completion Date
Nov 2011Actual
Brief Summary
This is a retrospective chart review and will assess changes in IOP after treatment with any fixed combination in patients who previously received monotherapy.
Glaucoma, Open-Angle
Ocular Hypertension
Any Fixed Combination Therapy
Ages Eligible for Study
Child (0-17)Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Diagnosis of glaucoma or ocular hypertension
Previously treated with monotherapy followed by fixed combination therapy for at least 12 weeks